JWC Article - To use With Providers - DOCUMENT ATTACHED

I’m sharing an important resource with you—the Journal of Wound Care (JWC) International Consensus Document on Best Practices for Wound Repair and Regeneration. Developed by industry leaders, this document provides valuable insights into the use of Cellular, Acellular, and Matrix-Like Products (CAMPs) in wound care.

To make it easier to digest, I’ve highlighted seven key takeaways that can be especially useful when onboarding new providers and educating them on best practices. This document is packed with clinical pearls that can help refine conversations with clinicians and drive success in the field.

1. Enhanced Healing Outcomes

• Faster wound closure: Amniotic membranes accelerate the healing process, reducing healing time compared to standard wound care.

• Tissue regeneration vs. repair: Unlike traditional dressings, amniotic membranes actively promote regeneration, leading to better structural integrity and long-term wound closure.

• Reduction in amputations: Studies show that early intervention with amniotic membranes significantly lowers the rate of minor and major amputations, particularly in diabetic foot ulcers (DFUs).

2. Early Application = Better Results

• Ideal for non-healing wounds: Amniotic membranes should be considered as early as 30 days into treatment if a wound shows no significant progress.

• Earlier adoption reduces overall treatment costs, hospitalization, and readmission rates.

• Competitive advantage for providers: Clinics that integrate amniotic membranes into their wound care protocol earlier position themselves as cutting-edge treatment centers.

3. Versatility & Broad Application

Amniotic membranes are effective in various wound types, including:

• Hard-to-heal wounds (DFUs, venous leg ulcers, pressure ulcers)

• Surgical wounds and incisions

• Traumatic wounds and burns

• Dermatological conditions (potential for expansion into additional specialties)

• Outpatient settings, making them an attractive option for clinics and specialty wound centers.

4. Economic & Reimbursement Advantages

• Lower overall healthcare costs:

  • Fewer emergency visits and readmissions

  • Reduced need for extended wound care treatments

  • Minimized long-term disability costs associated with non-healing wounds

5. Advanced Bioengineering & Science-Backed Innovation

• Amniotic membranes incorporate the latest advancements in regenerative medicine, positioning them as cutting-edge solutions.

• They contain growth factors, extracellular matrices, and bioactive proteins that stimulate natural healing.

• They are more advanced than traditional wound dressings, which serve only as passive barriers.

6. Regulatory & Safety Assurance

• Generally no risk of rejection or infection due to careful processing and preservation methods.

• Amniotic membranes are bioresorbable and biocompatible, ensuring seamless integration into tissue.

7. Competitive Edge for Healthcare Providers

• Stand out from competitors: Offering advanced wound care solutions attracts more referrals from general practitioners and specialists.

• Improved patient satisfaction: Patients benefit from quicker healing, less pain, and better outcomes.

• Positioning as a leader in regenerative medicine.

I hope this serves as a helpful tool in strengthening your approach and supporting your efforts with providers. Please take some time to review it—I truly believe this can have a big impact on the wound care specialists you’re working to onboard. Best of luck out there!

Warmest Regards,

Nikki Johnson